Valvular heart disease: Diagnosis and management

Mayo Clinic Proceedings

Volumn 85, Issue 5, 2010, Pages 483-500

  Maganti, Kameswari ^a   Rigolin, Vera H ^a   Sarano, Maurice Enriquez ^b   Bonow, Robert O ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANOREXIGENIC AGENT; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERGOT DERIVATIVE; ERGOTAMINE; HYDRALAZINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NIFEDIPINE; PENICILLIN G; VASODILATOR AGENT; WARFARIN;

AORTA STENOSIS; AORTA VALVE REGURGITATION; BACTERIAL ENDOCARDITIS; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL EVALUATION; CLINICAL PRACTICE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; DISEASE COURSE; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EMBOLISM; EXERCISE TEST; HEART ATRIUM FIBRILLATION; HEART CATHETERIZATION; HEART LEFT VENTRICLE HYPERTROPHY; HEART VALVE PROSTHESIS; HUMAN; MITRAL VALVE REGURGITATION; MITRAL VALVE STENOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PERCUTANEOUS BALLOON VALVOTOMY; PERCUTANEOUS CORONARY INTERVENTION; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PREGNANCY; RHEUMATIC FEVER; RHEUMATIC HEART DISEASE; RISK FACTOR; STREPTOCOCCUS INFECTION; SURGICAL APPROACH; THORAX RADIOGRAPHY; VALVULAR HEART DISEASE; VALVULOPLASTY;

EID: 77951820306     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/mcp.2009.0706     Document Type: Conference Paper

References (46)

1. Otto CM. Bonow RO. Valvular heart disease. In: Libby P, Bonow RO, Mann DL, Zipes DP, eds. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 8th ed. Philadelphia, PA: WB Saunders; 2007:1625-1712.
2. Bonow RO, Carabello BA, Chatterjee K, et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Valvular Heart Disease). Circulation. 2008;118:e523-e661.
3. Ross J Jr, Braunwald E. Aortic stenosis. Circulation. 1968;38(1)(suppl):61-67.
4. Bouma BJ, van den Brink RBA, van der Meulen JH, et al. To operate or not in elderly patients with aortic stenosis: the decision and its consequences. Heart. 1999;82:143-148.
5. Bach DS, Siao D, Girard SE, Duvernoy C, McCallister BD Jr, Gualano SK. Evaluation of patients with severe symptomatic aortic stenosis who do not undergo aortic valve replacement: the potential role of subjectively overestimated operative risk. Circ Cardiovasc Qual Outcomes. 2009;2:533-539.
6. Pellikka PA, Sarano ME, Nishimura RA, et al. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation. 2005;111(24):3290-3295.
7. Rahimtoola SH. Aortic valve disease. In: Fuster V, O'Rourke RA, Walsh RA, Poole-Wilson P, eds. Hurst's The Heart. 12th ed. New York, NY: McGraw-Hill; 2008:1697-1730.
8. Baumgartner H, Hung J, Bernejo J, et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr. 2009;22:1-23.
9. Lindroos M, Kupari M, Heikkila J, Tilvis R. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol. 1993;21:1220-1225. (Pubitemid 23106200)
10. Stewart BF, Siscovick D, Lind BK, et al; Cardiovascular Health Study. Clinical factors associated with calcific aortic valve disease. J Am Coll Cardiol. 1997;29(3):630-634.
11. Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med. 1999;341:142-147.
12. Aronow WS, Schwartz KS, Koenigsberg M. Correlation of serum lipids, calcium, and phosphorus, diabetes mellitus and history of systemic hypertension with presence or absence of calcified or thickened aortic cusps or root in elderly patients. Am J Cardiol. 1987;59:998-999. (Pubitemid 17074253)
13. Boon A, Cheriex E, Lodder J, Kessels F. Cardiac valve calcification: characteristics of patients with calcification of the mitral annulus or aortic valve. Heart. 1997;78:472-474. (Pubitemid 27515107)
14. Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837-1847. (Pubitemid 28213628)
15. Picano E, Pibarot P, Lancellotti P, Monin JL, Bonow RO. The emerging role of exercise testing and stress echocardiography in valvular heart disease. J Am Coll Cardiol. 2009;54:2251-2260.
16. Connolly HM, Oh JK, Schaff HV, et al. Severe aortic stenosis with low transvalvular gradient and severe left ventricular dysfunction: result of aortic valve replacement in 52 patients. Circulation. 2000;101:1940-1946.
17. Messika-Zeitoun D, Aubry MC, Detaint D, et al. Evaluation and clinical implications of aortic valve calcification measured by electron-beam computed tomography. Circulation. 2004;110:356-362. (Pubitemid 38955506)
18. Kilner PJ, Manzara CC, Mohiaddin RH, et al. Magnetic resonance jet velocity mapping in mitral and aortic valve stenosis. Circulation. 1993;87:1239-1248. (Pubitemid 23110396)
19. Chan KL, Teo K, Dumesnil JG, et al. Effect of lipid lowering with rosuvastatin on progression of aortic stenosis: results of the Aortic Stenosis Progression Observation: Measuring Effects of Rosuvastatin (ASTRONOMER) trial. Circulation. 2010;121(2):306-314.
20. Lieberman EB, Bashore TM, Hermiller JB, et al. Balloon aortic valvuloplasty in adults: failure of procedure to improve long term survival. J Am Coll Cardiol. 1995;26:1522-1528.
21. Zajarias A, Cribier AG. Outcomes and safety of percutaneous aortic valve replacement. J Am Coll Cardiol. 2009;53(20):1829-1836.
22. Tadros TM, Klein MD, Shapira OM. Ascending aortic dilatation associated with bicuspid aortic valve: pathophysiology, molecular biology, and clinical implications. Circulation. 2009;119(6):880-890.
23. Otto CM. The left ventricular response to chronic pressure and/or volume overload and aortic regurgitation. In: Otto CM, ed. Valvular Heart Disease. 2nd ed. Philadelphia, PA: WB Saunders; 2003:302-335.
24. Rigolin VH, Bonow RO. Hemodynamic characteristics and progression to heart failure in regurgitant lesions. Heart Fail Clin. 2006;2:453-460.
25. Carabello BA. Progress in mitral and aortic regurgitation. Prog Cardiovasc Dis. 2001;43:457-475.
26. Enriquez-Sarano M, Tajik AJ. Clinical practice: aortic regurgitation. N Engl J Med. 2004;351:1539-1546.
27. Bekeredjian R, Grayburn PA. Valvular heart disease: aortic regurgitation. Circulation. 2005;112(1):125-134. (Pubitemid 40962578)
28. Roes SD, Hammer S, van der Geest RJ, et al. Flow assessment through four heart valves simultaneously using 3-dimensional 3-directional velocity-encoded magnetic resonance imaging with retrospective valve tracking in healthy volunteers and patients with valvular regurgitation [published online ahead of print August 29, 2009]. Invest Radiol. doi:10.1097/RLI.0b013e3181ae99b5.
29. Borer JS, Bonow RO. Contemporary approach to aortic and mitral regurgitation. Circulation. 2003;108:2432-2438. (Pubitemid 37444401)
30. Dujardin KS, Enriquez-Sarano M, Schaff HV, et al. Mortality and morbidity of aortic regurgitation in clinical practice: a long-term follow-up study. Circulation. 1999;99:1851-1857. (Pubitemid 29181414)
31. Greenberg BH, DeMots H, Murphy E, et al. Beneficial effects of hydralazine on rest and exercise hemodynamics in patients with chronic severe aortic insufficiency. Circulation. 1980;62:49-55. (Pubitemid 10083096)
32. Shen WF, Roubin GS, Hirasawa K, et al. Noninvasive assessment of acute effects of nifedipine on rest and exercise hemodynamics and cardiac function in patients with aortic regurgitation. J Am Coll Cardiol. 1984;4:902-907. (Pubitemid 15206637)
33. Lin M, Chiang HT, Lin SL, et al. Vasodilator therapy in chronic asymptomatic aortic regurgitation: enalapril versus hydralazine therapy. J Am Coll Cardiol. 1994;24:1046-1053. (Pubitemid 24306417)
34. Levine RA, Schwammenthal E. Ischemic mitral regurgitation on the threshold of a solution: from paradoxes to unifying concepts. Circulation. 2005;112:745-758. (Pubitemid 41099055)
35. Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun D, et al. Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med. 2005;352(9):875-883. (Pubitemid 40300296)
36. Zoghbi WA, Enriquez-Sarano M, Foster E, et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr. 2003;16:777.
37. Rosenhek R, Rader F, Klaar U, et al. Outcome of watchful waiting in asymptomatic severe mitral regurgitation. Circulation. 2006;113(18):2238-2244. (Pubitemid 43755147)
38. Enriquez-Sarano M, Schaff HV, Orszulak TA, Tajik AJ, Bailey KR, Frye RL. Valve repair improves the outcome of surgery for mitral regurgitation: a multivariate analysis. Circulation. 1995;91:1022-1028.
39. Capomolla S, Febo O, Gnemmi M, et al. Beta blockade in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol. Am Heart J. 2000;139:596-608. (Pubitemid 30207784)
40. Linde C, Leclercq C, Rex S, et al. Long term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation In Cardiomyopathy (MUSTIC) study. J Am Coll Cardiol. 2002;40:111-118. (Pubitemid 34701385)
41. Breithardt OA, Sinha AM, Schammenthal E, et al. Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure. J Am Coll Cardiol. 2003;41:765-770.
42. Alqoofi F, Feldman T. Percutaneous approaches to mitral regurgitation. Curr Treat Options Cardiovasc Med. 2009;11(6):476-482.
43. Wilkins GT, Weymen AE, Abascal VM, Block PC, Palacios IF. Percutaneous balloon dilation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilatation. Br Heart J. 1988;60:299-308.
44. Warnes CA. Pregnancy and heart disease. In: Libby P, Bonow RO, Mann DL, Zipes DP, eds. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 8th ed. Philadelphia, PA: WB Saunders; 2007:1967-1982.
45. Banbury MK, Cosgrove DM III, White JA, Blackstone EH, Frater RW, Okies JE. Age and valve size effect on the long-term durability of the Carpentier-Edwards aortic pericardial bioprosthesis. Ann Thorac Surg. 2001;72:753-757.
46. Wilson W, Taubert KA, Gewitz M, et al. Prevention of endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2007;116:1736-1754.